Search Within

Eytan Moshe Stein

  1. "American Journal of Hematology"
Formats
  1. Journal Article (2)
  2. Research Letter (2)
  3. Correspondence (1)
  4. Review (1)
Groups
  1. Adult Leukemia (6)
  2. Center for Hematologic Malignancies (6)
  3. Department of Medicine (6)
  4. Hematologic Malignancies, Division of (6)
  5. Weinberg Fellows (4)
  6. Biostatistics Service (3)

More Groups

People
  1. Aaron Goldberg (3)
  2. Boglarka Gyurkocza (3)
  3. Brian Shaffer (3)
  4. Martin Tallman (3)
  5. Sean Devlin (3)
  6. Sergio Giralt (3)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2021 (2)
Publications
  1. American Journal of Hematology (6)
Publishers
  1. John Wiley & Sons, Inc. (5)
  2. John Wiley & Sons (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia—A multicenter cohort study
    Correspondence

    Bewersdorf, J. P.; Shimony, S.; Shallis, R. M.; Liu, Y.; Berton, G.; Schaefer, E. J.; Zeidan, A. M.; Goldberg, A.; Stein, E.; Marcucci, G.; more...
    American Journal of Hematology (2024)

    Fulltext@MSK | Save
  • Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia
    Journal Article

    Nath, K.; Lee, J.; Elko, T. A.; Levy, L.; Preston, E.; Devlin, S. M.; Ponce, D. M.; Lin, R. J.; Shaffer, B. C.; Cho, C.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Safety, efficacy, and PK/PD of vorasidenib in previously treated patients with mIDH1/2 hematologic malignancies: A phase 1 study
    Research Letter

    DiNardo, C. D.; De Botton, S.; Pollyea, D. A.; Stone, R. M.; Altman, J. K.; Fathi, A. T.; Limsakun, T.; Liang, M.; Choe, S.; Hossain, M.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
    Journal Article

    Stahl, M.; Derkach, A.; Farnoud, N.; Bewersdorf, J. P.; Robinson, T.; Famulare, C.; Cho, C.; Devlin, S.; Menghrajani, K.; Patel, M. A.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Differentiation syndrome with lower-intensity treatments for acute myeloid leukemia
    Review

    Fathi, A. T.; Stein, E. M.; DiNardo, C. D.; Levis, M. J.; Montesinos, P.; de Botton, S.
    American Journal of Hematology (2021)

    Fulltext@MSK | Save
  • The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy
    Research Letter

    Ball, B. J.; Hsu, M.; Devlin, S. M.; Arcila, M.; Roshal, M.; Zhang, Y.; Famulare, C. A.; Goldberg, A. D.; Cai, S. F.; Dunbar, A.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save